Options: Hide MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Blood glucose decreased | x | x | x | x | x | x | x | |||||||||||||||
Coma | x | |||||||||||||||||||||
Diabetes mellitus | x | x | x | |||||||||||||||||||
Diabetic | x | |||||||||||||||||||||
Diabetic ketoacidosis | x | x | ||||||||||||||||||||
Hyperglycaemia | x | x | x | x | x | x | x | |||||||||||||||
Hypoglycaemia | x | |||||||||||||||||||||
Nephropathy | x | |||||||||||||||||||||
Neuropathy | x | |||||||||||||||||||||
Obesity | x | |||||||||||||||||||||
Retinal disorder | x | |||||||||||||||||||||
Type 1 diabetes mellitus | x | x | ||||||||||||||||||||
Type 2 diabetes mellitus | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||
Weight decreased | x | x | x | x | x | x | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |